| Dr Mary Ellen Fisher, MD | |
|
1800 E Park Ave, State College, PA 16803-6701 | |
| (814) 231-7000 | |
| (814) 234-6795 |
| Full Name | Dr Mary Ellen Fisher |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 35 Years |
| Location | 1800 E Park Ave, State College, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093797821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD048331L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger-community Medical Center | Scranton, PA | Hospital |
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Geisinger-lewistown Hospital | Lewistown, PA | Hospital |
| Geisinger-bloomsburg Hospital | Bloomsburg, PA | Hospital |
| Geisinger Medical Center | Danville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geisinger-hm Joint Venture Llc | 1355676370 | 306 |
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
Novel nanomaterials derived from cellulose have many promising industrial applications, are biobased and biodegradable, and can be produced at relatively low cost. Their potential toxicity-whether ingested, inhaled, on contact with the skin, or on exposure to cells within the body-is a topic of intense discussion, and the latest evidence and insights on cellulose nanocrystal toxicity are presented in a Review article in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Cerner Corporation and Baxa Corporation have signed a strategic reseller agreement for the Baxa DoseEdge Pharmacy Workflow Manager. The agreement enables Cerner to market and resell the Baxa DoseEdge System as part of an integrated Cerner offering. Cerner clients now have access to a broader suite of solutions and certified integration for dose tracking from compounding to delivery.
Two studies published in the New England Journal of Medicine have found that inhaling mists of salt water can help clear mucus and improve lung function for cycstic fibrosis sufferers.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a price to the public of $7.25 per share.
› Verified 9 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
Novel nanomaterials derived from cellulose have many promising industrial applications, are biobased and biodegradable, and can be produced at relatively low cost. Their potential toxicity-whether ingested, inhaled, on contact with the skin, or on exposure to cells within the body-is a topic of intense discussion, and the latest evidence and insights on cellulose nanocrystal toxicity are presented in a Review article in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Cerner Corporation and Baxa Corporation have signed a strategic reseller agreement for the Baxa DoseEdge Pharmacy Workflow Manager. The agreement enables Cerner to market and resell the Baxa DoseEdge System as part of an integrated Cerner offering. Cerner clients now have access to a broader suite of solutions and certified integration for dose tracking from compounding to delivery.
Two studies published in the New England Journal of Medicine have found that inhaling mists of salt water can help clear mucus and improve lung function for cycstic fibrosis sufferers.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a price to the public of $7.25 per share.
› Verified 9 days ago
| Entity Name | Geisinger-hm Joint Venture Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144876137 PECOS PAC ID: 1355676370 Enrollment ID: O20190826000803 |
News Archive
Novel nanomaterials derived from cellulose have many promising industrial applications, are biobased and biodegradable, and can be produced at relatively low cost. Their potential toxicity-whether ingested, inhaled, on contact with the skin, or on exposure to cells within the body-is a topic of intense discussion, and the latest evidence and insights on cellulose nanocrystal toxicity are presented in a Review article in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Cerner Corporation and Baxa Corporation have signed a strategic reseller agreement for the Baxa DoseEdge Pharmacy Workflow Manager. The agreement enables Cerner to market and resell the Baxa DoseEdge System as part of an integrated Cerner offering. Cerner clients now have access to a broader suite of solutions and certified integration for dose tracking from compounding to delivery.
Two studies published in the New England Journal of Medicine have found that inhaling mists of salt water can help clear mucus and improve lung function for cycstic fibrosis sufferers.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a price to the public of $7.25 per share.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary Ellen Fisher, MD Po Box 197, State College, PA 16804-0197 Ph: (814) 235-1208 | Dr Mary Ellen Fisher, MD 1800 E Park Ave, State College, PA 16803-6701 Ph: (814) 231-7000 |
News Archive
Novel nanomaterials derived from cellulose have many promising industrial applications, are biobased and biodegradable, and can be produced at relatively low cost. Their potential toxicity-whether ingested, inhaled, on contact with the skin, or on exposure to cells within the body-is a topic of intense discussion, and the latest evidence and insights on cellulose nanocrystal toxicity are presented in a Review article in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Cerner Corporation and Baxa Corporation have signed a strategic reseller agreement for the Baxa DoseEdge Pharmacy Workflow Manager. The agreement enables Cerner to market and resell the Baxa DoseEdge System as part of an integrated Cerner offering. Cerner clients now have access to a broader suite of solutions and certified integration for dose tracking from compounding to delivery.
Two studies published in the New England Journal of Medicine have found that inhaling mists of salt water can help clear mucus and improve lung function for cycstic fibrosis sufferers.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a price to the public of $7.25 per share.
› Verified 9 days ago
Jerome D. Derdel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-234-6726 Fax: 814-234-1553 | |
Dr. Ari Reuben Geselowitz, MD Radiology Medicare: Medicare Enrolled Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-234-6137 Fax: 814-234-6795 | |
Anna C Hood, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1850 E Park Ave, Suite 105, State College, PA 16803 Phone: 814-231-3147 Fax: 814-231-7351 | |
Veeral B. Patel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-234-6726 Fax: 814-234-1553 | |
Dr. Paul Benjamin Stoddard, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-231-7000 | |
Dr. Gregory Ross Weimer, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-234-6137 Fax: 814-234-6795 |